News

company

year

domain

Mirai Bio Announces Partnership with Thermo Fisher Scientific to Accelerate Development of Genetic Medicines

Mirai Bio 05.20.2025

Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare

Etiome 04.24.2025

Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease

Repertoire® Immune Medicines 04.23.2025

Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease

Valo 04.01.2025

Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science

Lila Sciences 03.10.2025

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies

Metaphore Biotechnologies 11.20.2024

Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer

Ampersand Biomedicines, Montai Therapeutics 11.20.2024

Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease

Vesalius Therapeutics 11.12.2024

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry

Mirai Bio 09.26.2024

Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer

Quotient Therapeutics 08.28.2024

Loading